Die jährlichen Ausschreibungen mit vorgegebenen Themen (Topics) werden im Rahmen strategischer Planungen und entsprechend ihrer erwarteten Wirkung in den 6 Bereichen („Destinations“) des Clusters 1 „Gesundheit“ gebündelt.
Alle Details zu den aktuellen Ausschreibungen finden Sie auf dem „Funding & tender opportunities“- Portal der Europäischen Kommission.
Sind Sie Newcomer? Basisinfo gibt es in unseren „Online Infopaket: Basiswissen Horizon Europe“
DESTINATION – STAYING HEALTHY IN A RAPIDLY CHANGING SOCIETY
- HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
DESTINATION – LIVING AND WORKING IN A HEALTH-PROMOTING ENVIRONMENT
- HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
- HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
DESTINATION - TACKLING DISEASES AND REDUCING DISEASE BURDEN
- HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
- HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
- HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
- HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
DESTINATION - ENSURING EQUAL ACCESS TO INNOVATIVE, SUSTAINABLE, AND HIGH-QUALITY HEALTHCARE
- HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
DESTINATION - MAINTAINING AN INNOVATIVE, SUSTAINABLE, AND COMPETITIVE EU HEALTH INDUSTRY
- HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals